Concepedia

Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline

Rachel L. Schassburger, Melissa Levin, Matthew T. Weaver, Matthew I. Palmatier, Anthony R. Caggiula, Eric C. Donny, Alan F. Sved

Psychopharmacology · 2014 · 19 citations · 28 references

DOIFull text

Open access

Concepts

References

28

Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Douglas E. Jorenby · JAMA · 2006 · 1.7K citations

, , +17

Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

David Gonzales · JAMA · 2006 · 1.4K citations

, , +17

Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine

Marina R. Picciotto, Michèle Zoli, Roberto Rimondini et al. · Nature · 1998 · 1.3K citations

, , +16

Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Jotham W. Coe, Paige R. Brooks, Michael G. Vetelino et al. · Journal of Medicinal Chemistry · 2005 · 933 citations · Full text

, , +17

Nicotine maintains robust self-administration in rats on a limited-access schedule

William A. Corrigall, Kathleen M. Coen · Psychopharmacology · 1989 · 589 citations

, , +14